Personensuche
Personensuche
Es wurde 1 Person gefunden.
Funktionen
-
, Zentrum für Konservative Onkologie
Aktuelle Veranstaltungen
Vergangene Veranstaltungen (max. 10)
-
2023 SS
-
2022 WS
-
2022 SS
-
2021 WS
-
2021 SS
-
2020 WS
-
2020 SS
-
2019 WS
Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.
-
Preoperative chemotherapy versus chemoradiotherapy in locally advanced adenocarcinomas of the oesophagogastric junction (POET) : Long-term results of a controlled randomised trialIn: European Journal of Cancer (EJC) Jg. 81 (2017) S. 183 - 190Online Volltext: dx.doi.org/
-
Quality-of-life and performance status results from the phase III RAINBOWstudy of ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated gastric or gastroesophageal junction adenocarcinomaIn: Annals of Oncology Jg. 27 (2016) Nr. 4, S. 673 - 679Online Volltext: dx.doi.org/ (Open Access)
-
Prediction of prognosis after trimodal therapy in patients with locally advanced squamous cell carcinoma of the oesophagusIn: European Journal of Cancer Jg. 48 (2012) Nr. 16, S. 2977 - 2982Online Volltext: dx.doi.org/
-
15-Year (very) long-term survival (VLTS) and competing risks (CR) analysis of induction (IND) chemotherapy (CTX) with three cycles cisplatin (P) / etoposide (E) followed by concurrent (CC) chemoradiation (CTX/RTX) PE/45 GY (1.5 GY BID) pkus surgery (S) = TRIMIn: Journal of Thoracic Oncology Jg. 6 (2011) Nr. 6, Suppl. 2, S.S 492 - S493
-
Long-term survival (LTS) and competing risks within a prospective multi center German randomized trial comparing induction chemotherapy (CTx) followed by concurrent (cc) chemoradiation (CTx/RTx) plus surgery (SURG; TRIMODALITY) supplemented by PCI versus local treatment (Tx) alone (SURG + RTx) in operable IIIA NSCLC.In: Journal of Clinical Oncology (JCO) Jg. 29 (2011) Nr. 15_suppl, S. 7042Online Volltext: dx.doi.org/
-
Long-term survival (LTS) and competing risks within a prospective multicenter german randomized trial comparing induction (IND) chemotherapy (CTX) followed by concurrent (CC) chemoradiation (CTX/RTX) plus surgery (S) (= Trimodality) supplemented by PCI VEIn: Journal of Thoracic Oncology Jg. 6 (2011) Nr. 6, Suppl. 2, S. 495
-
S3-Leitlinie „Magenkarzinom” – Diagnostik und Therapie der Adenokarzinome des Magens und ösophagogastralen ÜbergangsIn: Zeitschrift für Gastroenterologie Jg. 49 (2011) Nr. 4, S. 461 - 531Online Volltext: dx.doi.org/
-
Predictive factors in locally advances squamous cell carcinoma (SCC) of the oesophagus treated with preoperative radiochemotherapy (RCT) and surgery
35th ESMO Congress, Milan, Italy 8–12 October 2010,In: Annals of Oncology Jg. 21 (2010) Nr. Suppl. 8, S. 252 - 252 -
Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagusIn: Journal of Clinical Oncology Jg. 23 (2005) Nr. 10, S. 2310 - 2317Online Volltext: dx.doi.org/
-
Prädiktive Bedeutung des endosonographischen (EUS) Stagings bei lokal fortgeschrittenem Adenokarzinom des Magens (MC) oder ösophagogastralen Übergangs (AEG) : Analyse von Daten einer perioperativen AIO-CAO Phase II Studie
124. Kongress der Deutschen Gesellschaft für Innere Medizin e.V. (DGIM) ; 14. - 17. April 2018, Mannheim, Germany,In: Der Internist Jg. 59 (2018) Nr. Supplement 1: Abstractband, S. S43 - S44Online Volltext: dx.doi.org/ (Open Access) -
Na-Folfiri plus sunitinib versus Na-Folfiri alone in advanced chemorefractory esophagogastric cancer patients : A randomized double-blinded placebo-controlled multicentric AIO phase II trial
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie, 18.-22. Oktober 2013, Wien, Österreich,In: Onkologie Jg. 36 (2013) Nr. Suppl. 7, S. 74Online Volltext: dx.doi.org/